WO2007060116A3 - Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen - Google Patents

Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen Download PDF

Info

Publication number
WO2007060116A3
WO2007060116A3 PCT/EP2006/068471 EP2006068471W WO2007060116A3 WO 2007060116 A3 WO2007060116 A3 WO 2007060116A3 EP 2006068471 W EP2006068471 W EP 2006068471W WO 2007060116 A3 WO2007060116 A3 WO 2007060116A3
Authority
WO
WIPO (PCT)
Prior art keywords
keratin
effector molecules
binding
coupling
production
Prior art date
Application number
PCT/EP2006/068471
Other languages
English (en)
French (fr)
Other versions
WO2007060116A2 (de
Inventor
Heiko Barg
Burghard Liebmann
Martin Voelkert
Arne Ptock
Heike Reents
Original Assignee
Basf Ag
Heiko Barg
Burghard Liebmann
Martin Voelkert
Arne Ptock
Heike Reents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Heiko Barg, Burghard Liebmann, Martin Voelkert, Arne Ptock, Heike Reents filed Critical Basf Ag
Priority to EP06829995A priority Critical patent/EP1968642A2/de
Priority to BRPI0618933A priority patent/BRPI0618933A2/pt
Priority to AU2006316536A priority patent/AU2006316536A1/en
Priority to US12/094,803 priority patent/US20090156485A1/en
Priority to CA002630696A priority patent/CA2630696A1/en
Priority to JP2008541700A priority patent/JP2009521404A/ja
Publication of WO2007060116A2 publication Critical patent/WO2007060116A2/de
Publication of WO2007060116A3 publication Critical patent/WO2007060116A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Herstellung von keratinbindenden Effektormolekülen sowie Zwischenprodukte und Endprodukte des erfindungsgemäßen Verfahrens und die Vewendung der erfindungsgemäß hergestellten keratinbindenden Effektormoleküle in Dermokosmetika.
PCT/EP2006/068471 2005-11-24 2006-11-15 Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen WO2007060116A2 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP06829995A EP1968642A2 (de) 2005-11-24 2006-11-15 Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen
BRPI0618933A BRPI0618933A2 (pt) 2005-11-24 2006-11-15 método para produzir uma molécula efetora que se liga à queratina, molécula efetora que se liga à queratina, uso das moléculas efetoras que se ligam à queratina, composto, e, dermocosmético
AU2006316536A AU2006316536A1 (en) 2005-11-24 2006-11-15 Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules that support carboxylic groups or sulfonic acid groups
US12/094,803 US20090156485A1 (en) 2005-11-24 2006-11-15 Method for coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups
CA002630696A CA2630696A1 (en) 2005-11-24 2006-11-15 Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules that support carboxylic groups or sulfonic acid groups
JP2008541700A JP2009521404A (ja) 2005-11-24 2006-11-15 ケラチン結合ポリペプチドとカルボキシル基又はスルホン酸基を有するエフェクター分子とのカップリング方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05111235.7 2005-11-24
EP05111235 2005-11-24
EP06116395.2 2006-06-30
EP06116395 2006-06-30

Publications (2)

Publication Number Publication Date
WO2007060116A2 WO2007060116A2 (de) 2007-05-31
WO2007060116A3 true WO2007060116A3 (de) 2008-03-20

Family

ID=38040499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/068471 WO2007060116A2 (de) 2005-11-24 2006-11-15 Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen

Country Status (7)

Country Link
US (1) US20090156485A1 (de)
EP (1) EP1968642A2 (de)
JP (1) JP2009521404A (de)
AU (1) AU2006316536A1 (de)
BR (1) BRPI0618933A2 (de)
CA (1) CA2630696A1 (de)
WO (1) WO2007060116A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7220405B2 (en) 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
EP1957111A2 (de) * 2005-11-24 2008-08-20 Basf Se Keratinbindende effektormoleküle und verfahren zu deren herstellung
US20090098074A1 (en) * 2005-12-01 2009-04-16 Basf Se Keratin-Binding Effector Molecules Containing Reactive Dyes
EP2164864B1 (de) * 2007-06-20 2014-12-03 Basf Se Synthetische repetitive proteine, deren herstellung und verwendung
EP2026529A1 (de) 2007-07-12 2009-02-18 Wayport, Inc. Vorrichtungsspezifische Autorisierung an verteilten Standorten
DE102007039954A1 (de) * 2007-08-23 2009-02-26 Henkel Ag & Co. Kgaa Reduktive Entfärbung keratinhaltiger Fasern
EP2042155A1 (de) * 2007-09-28 2009-04-01 Basf Se Verfahren zum Entfernen von wasserunlöslichen Substanzen von Substratoberflächen
WO2009112301A2 (de) * 2008-03-10 2009-09-17 Basf Se Polypeptidwirkstoffe in der form von konjugaten aus keratinbindenden polypeptiden, polymeren und effektormolekülen, verfahren zu ihrer herstellung und ihre verwendung
WO2010010145A1 (en) * 2008-07-23 2010-01-28 Basf Se Keratin-binding polypeptides and method for their identification
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
WO2012022478A2 (en) 2010-08-19 2012-02-23 Merz Pharma Gmbh & Co. Kgaa Filler composition comprising beta-glucans
JP5973194B2 (ja) * 2012-03-15 2016-08-23 東洋エアゾール工業株式会社 紫外線蛍光エアゾール組成物および人体装飾顕示方法
CN105073084B (zh) * 2013-05-16 2018-01-19 株式会社漫丹 整发剂组合物
US9757209B2 (en) * 2013-07-03 2017-09-12 Essential Dental Systems, Inc. Compositions and methods for dental applications involving zinc-oxide cements
US9672952B2 (en) 2013-08-14 2017-06-06 Industrial Technology Research Institute Polymer and conductive composition
JP6463745B2 (ja) * 2013-10-11 2019-02-06 ベータ ファーマシューティカルズ カンパニー リミテッド イコチニブ含有皮膚外用医薬組成物及びその応用
DE102014207919A1 (de) * 2014-04-28 2015-10-29 Beiersdorf Ag Sonnenschutzmittel mit reduzierter Neigung zur Textilverfleckung I
DE102014207916A1 (de) * 2014-04-28 2015-10-29 Beiersdorf Aktiengesellschaft Sonnenschutzmittel mit reduzierter Neigung zur Textilverfleckung II
DE102014207924A1 (de) * 2014-04-28 2015-10-29 Beiersdorf Ag Sonnenschutzmittel mit reduzierter Neigung zur Textilverfleckung IV
WO2021123116A1 (en) * 2019-12-19 2021-06-24 Skinosive Adhesive photoprotective compounds and uses thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2241702A (en) * 1990-02-08 1991-09-11 Cird Galderma Antibodies binding to stratum corneum of the epidermis
JPH0429912A (ja) * 1990-05-25 1992-01-31 Takara Shuzo Co Ltd 新規化粧料
EP0634161A1 (de) * 1992-12-08 1995-01-18 Kanebo, Ltd. Haarfärbemittel oder kosmetische zusammensetzung, vorbehandlungsagent sowie verfahren zur haarfärbung
EP1470824A1 (de) * 2002-12-10 2004-10-27 L-MAbs B.V. Proteine mit hoher Affinität für kosmetische Substanzen mit gesteuerter Anwendung
WO2005115306A2 (de) * 2004-05-24 2005-12-08 Basf Aktiengesellschaft Keratin-bindende polypeptide
WO2006097432A2 (de) * 2005-03-14 2006-09-21 Basf Aktiengesellschaft Keratin-biktdende desmoplakinpolypeptidsequenzen
WO2006136607A2 (de) * 2005-06-24 2006-12-28 Basf Aktiengesellschaft Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10318526A1 (de) * 2003-04-24 2004-11-11 Beiersdorf Ag Reinigungsemulsion mit hohem Fettgehalt

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2241702A (en) * 1990-02-08 1991-09-11 Cird Galderma Antibodies binding to stratum corneum of the epidermis
JPH0429912A (ja) * 1990-05-25 1992-01-31 Takara Shuzo Co Ltd 新規化粧料
EP0634161A1 (de) * 1992-12-08 1995-01-18 Kanebo, Ltd. Haarfärbemittel oder kosmetische zusammensetzung, vorbehandlungsagent sowie verfahren zur haarfärbung
EP1470824A1 (de) * 2002-12-10 2004-10-27 L-MAbs B.V. Proteine mit hoher Affinität für kosmetische Substanzen mit gesteuerter Anwendung
WO2005115306A2 (de) * 2004-05-24 2005-12-08 Basf Aktiengesellschaft Keratin-bindende polypeptide
WO2006097432A2 (de) * 2005-03-14 2006-09-21 Basf Aktiengesellschaft Keratin-biktdende desmoplakinpolypeptidsequenzen
WO2006136607A2 (de) * 2005-06-24 2006-12-28 Basf Aktiengesellschaft Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FONTAO LIONEL ET AL: "INTERACTION OF THE BULLOUS PEMPHIGOID ANTIGEN 1 (BP230) AND DESMOPLAKIN WITH INTERMEDIATE FILAMENTS IS MEDIATED BY DISTINCT SEQUENCES WITHIN THEIR COOH TERMINUS", MOLECULAR BIOLOGY OF THE CELL, BETHESDA, MD, US, vol. 14, no. 5, May 2003 (2003-05-01), pages 1978 - 1992, XP009085452, ISSN: 1059-1524 *

Also Published As

Publication number Publication date
WO2007060116A2 (de) 2007-05-31
BRPI0618933A2 (pt) 2016-09-13
US20090156485A1 (en) 2009-06-18
JP2009521404A (ja) 2009-06-04
AU2006316536A1 (en) 2007-05-31
EP1968642A2 (de) 2008-09-17
CA2630696A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
WO2007060116A3 (de) Keratinbindende effektormoleküle und verfahren zu deren herstellung durch kopplung keratinbindender polypeptide mit carboxylgruppen oder sulfonsäuregruppen tragenden effektormolekülen
IL242665B (en) Processes for preparing anti-tricyclo[3.2.2.0]non-6-ene-endo-8,endo-9-dicarboxylic acid anhydride
EP2592084B8 (de) Verfahren zur Herstellung von Pyripyropenderivate und Zwischenstoffe zur Herstellung davon
WO2007144424A3 (en) Processes for production of a starch hydrolysate
WO2007136752A3 (en) Erythropoietin compositions
EP2177267A4 (de) Katalysator zur herstellung von carbonsäureester, herstellungsverfahren dafür und verfahren zur herstellung von carbonsäureester
WO2006082251A3 (de) Neue hydrophobinfusionsproteine, deren herstellung und verwendung
WO2008135482A3 (de) Ionische flüssigkeiten mit polyethercarboxylaten als anionen, deren herstellung und verwendung
WO2008018930A3 (en) Ethanol production in non-recombinant hosts
EP1950197A4 (de) Verfahren zur herstellung von pentaerythritmercaptocarbonsäureester, durch dieses erhaltener pentaerythritmercaptocarbonsäureester und verwendung davon
WO2009092793A3 (de) Verfahren zur fermentativen herstellung von 1,5-diaminopentan
IL195178A0 (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
IL195177A0 (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
IL195176A0 (en) 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
WO2009074875A8 (en) Sound-absorbing, resistant panels and process for making same
EP1908749A4 (de) Verfahren zur herstellung von isocyanat, danach hergestelltes isocyanat und verwendung von isocyanat
WO2008066558A3 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
WO2007093627A3 (de) Biozide zusammensetzung
WO2007025861A3 (de) Modifizierte kohlenstoff-nanopartikel, verfahren zu deren herstellung und deren verwendung
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
WO2007014197A3 (en) Yeast expression vectors for production of itf
WO2010009879A3 (en) Methods for producing paricalcitol
EP1928255A4 (de) Verfahren zur herstellung von milchprodukten, dadurch erhaltene produkte und deren verwendung
WO2009147105A3 (en) Method for producing a casein hydrolysate
WO2010056089A3 (ko) 클레이 강화 폴리유산 수지 조성물, 이의 제조 방법 및 이를 이용한 성형품

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680051637.7

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2630696

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 12094803

Country of ref document: US

Ref document number: MX/a/2008/006673

Country of ref document: MX

Ref document number: 2008541700

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006829995

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006316536

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 569072

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2006316536

Country of ref document: AU

Date of ref document: 20061115

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006316536

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2006829995

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0618933

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080523